About
Board
Expert Index
Podcasts
News
Sign up
Contact

Visit

Home
Diseases

ALL

AML

CLL

Lymphoma

Multiple Myeloma

Myeloproliferative Neoplasms

View all Diseases
Trials
- POLARIX
- IELSG32
- ALL-RIC
- DESTINY
- COLUMBA
- PAVO
- HOVON-50
- OPTIMISMM
- ELOQUENT-3
- iNNOVATE
- View all trials
Medicines
- View all medicines
Topics

Measurable Residual Disease

Pharmacy

Nursing

Supportive Care

Transplantation

Disease Biology

View all Topics
Conferences
- ASCO 2018
- EHA 2018
- ESH AL 2018
- EMN 2018
- BSH 2018
- HOPA 2018
- EBMT 2018
- iwAL 2018
- UKONS 2017
- ASH 2017
- View upcoming conferences
- View previous conferences
Features

About
Board
Expert Index
Podcasts
News
Sign up
Contact

Channels

See our channels below

Newsletter

Sign up for the latest news and videos

Sign up

Popular videos

3:22

Is CLL curable today?

Michael Hallek
3:48

How far are we from a cure for CLL?

Thomas Kipps
3:06

Mechanism of action of venetoclax (ABT-199) and its side effects

William Wierda
13:09

Myeloma 2016: Panel discussion on novel treatments

Keith Stewart et al.
3:11

Highlights from the International Workshop of the German CLL Study Group

Michael Hallek

VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Please enter your details if you would like to receive the latest Hemonc news and updates

Continue

Video channels

Chronic Lymphocytic Leukemia
Follicular Lymphoma
Multiple Myeloma
B-Cell Lymphoma
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Diffuse Large B-Cell Lymphoma
Chronic Myeloid Leukemia
Amyloidosis
Hodgkin Lymphoma

Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

The content of VJHemOnc is intended for healthcare professionals

Cookie Policy
Terms of Use
Terms of Use
Privacy Policy